Several studies have shown increased plasma FGF21 levels in both obese and type 2 diabetic patients, which correlate with several factors involved in the metabolic syndrome, for example, nonalcoholic fatty liver disease and dyslipidemia [7–9]. This evidence concerns the gene FGF21 and metabolic syndrome.